White Papers
Dive into our comprehensive collection of white papers and gain a deeper understanding of Datwyler's expertise in pharmaceutical drug packaging. Uncover crucial topics like the significance of parenteral packaging for patient safety, strategies for safeguarding packaging from nitrosamines, and the effects of worldwide sustainability efforts on the pharmaceutical sector.
A New Frontier in Diabetes and Weight Management: The Rise of GLP-1 Receptor Agonists
GLP-1 receptor agonists are transforming how we treat diabetes and weight management. Download this new report to learn more about how this market has evolved and how GlobalData predicts it to grow from here. The report also discusses primary packaging considerations for this new class of medicine, including the sealing solutions available for guaranteeing patient safety and ease of use.
mRNA: The State of Play in Oncology and Infectious Disease
This report covers the rise of mRNA and explores the modality’s potential in a range of applications within the infectious disease and oncology fields. Leveraging GlobalData’s proprietary data and insights, the report will analyze the current state of play in both infectious disease and oncology pipelines and discuss the opportunities and challenges in both. While exploring challenges, the report will focus on primary packaging considerations, which play a critical role in getting innovative new drugs to patients safely and effectively.
.png "Portfolio Thumbnail (2)")
“P.E.R.F.E.C.T.” the Packaging Selection Process
Packaging decision-makers for injectable drugs understand how critical it is to select the right components for vials, cartridges, and pre-filled syringes. The stakes are high. The performance failure of stoppers, plungers and other elastomer components can pose serious consequences to patient health and compromise overall trust in the company for years to come. That’s why Datwyler has developed the P.E.R.F.E.C.T. pathway for navigating drug packaging selection. It aims to simplify the decision-making process, offering guidance on key considerations at every juncture.
EU GMP Annex 1 and Parenteral Packaging: A Quality by Design Approach to Sterile Manufacturing
Recent updates to the EU GMP Annex 1 have prompted pharmaceutical companies to adopt a Quality by Design approach to manufacturing and parenteral packaging, emphasizing contamination control. This informative white paper delves into the impact of the new regulations and provides guidance on achieving compliance through the selection of packaging components that meet the stringent industry standards.
Future-proofing Parenteral Packaging Against Nitrosamines
The discovery of large quantities of nitrosamines in many drugs has led to a high number of product recalls in recent years. This white paper discusses the issue of nitrosamine contamination and the response from regulators and industry. Download to learn about the causes of contamination and how to adapt your parenteral packaging – one potential source – to minimize the risk.
.png "Better PFS Thumbnail 2022 (2)")
Lessons from the Pandemic: Building a Better Prefilled Syringe
Prefilled syringes are increasingly being recognized as the safest method of packaging injectable drugs, and they offer a number of advantages when administering vaccines specifically. The sheer volume of injectables production necessitated by the pandemic has turned the spotlight on manufacturing processes and their ability to deliver high-quality products at scale in a short timespan. Inevitably this has also made manufacturers focus on the optimum design of prefilled syringes to balance performance, cost and ease of use. This white paper explores the challenges of packaging vaccines and how the design of prefilled syringes can be optimized through the selection of appropriate materials and components.
Why Pharma Should be Focusing on ESG
Sustainability should be a key priority of any company that aims to thrive in today’s society, and pharmaceutical organizations are no exception. As the pressure mounts for pharma to build a more sustainable future, there are numerous challenges for the industry to tackle. Download this free white paper to learn more about pharma’s ESG challenges and opportunities, including the role of the supply chain in curbing climate change.
.png "Patient Safety Thumbnail 2022 (1)")
The Pivotal Role of Packaging in Patient Safety
The concept of patient safety cuts through every facet of the healthcare sector, from drug development and product manufacturing to hygiene protocols and the instructions for use that accompany medical devices. In an industry that is judged by patient outcomes, any risk to patient health must be mitigated, whether in clinical trials, primary care or any other setting. In this white paper, we will examine the risks to patient safety that can emerge in the parenteral packaging supply chain and the mitigating measures that can be taken to ensure manufacturing processes eliminate those risks.
A Quality by Design Approach Toward Manufacturing of Elastomeric Components
For high-end markets that require the absolute best-in-class sealing solutions for their drug products, Datwyler introduced its most advanced manufacturing standard: FirstLine®. The FirstLine manufacturing environment is a fully integrated cleanroom that conforms to the highest of industry standards. A strict zero-defect philosophy is what makes FirstLine the best choice for customers seeking the highest quality and safest components. This white paper explores the state-of-the-art features of the FirstLine environment, explaining how it ensures contaminant and defect-free production for high-end drug products.